Skip to main content
Equibles

Caption Management, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to XERS Full portfolio

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,567,074
+$378,074 QoQ
Shares Held
197,863
-3.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#73
of 239 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Derivatives in XERS

reported options exposure · as of Jun 30, 2026
CallValue
$2,217,600
CallShares
280,000
PutValue
$3,512,520
PutShares
443,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. XERS ranks #7 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 258,331 $8,752,254
2 UTHR
UNITED THERAPEUTICS Corp
 9,333 $5,056,899
3 NBIX
Neurocrine Biosciences Inc
 29,500 $4,971,930
4 ANIP
Ani Pharmaceuticals Inc
 40,000 $3,311,200
5 PRGO
PERRIGO Co plc
 253,459 $2,633,439
6 KNSA
Kiniksa Pharmaceuticals International, plc
 25,000 $1,598,750
7 XERS
Xeris Biopharma Holdings, Inc.
This page 		197,863 $1,567,074
8 EOLS
Evolus, Inc.
 216,316 $1,501,233

All Filings in XERS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,512,520 443,500
2026-06-30 $2,217,600 280,000
2026-06-30 $1,567,074 197,863
2026-03-31 $2,339,720 403,400
2026-03-31 $1,189,000 205,000
2026-03-31 $2,572,300 443,500
2025-12-31 $968,690 123,400
2023-12-31 $104,340 44,400
2023-09-30 $82,584 44,400
2023-06-30 $116,328 44,400
2021-12-31 $139,468 47,600
2021-12-31 $139,468 47,600